Bristol-Myers Squibb CompanyBMY

Where BMY's P/E ratio sits inside its own 10-year distribution, with the yearly high, low and average.

$63.75-0.66 (-1.02%)Previous close
NYSEHealthcare

BMY P/E ratio: current value, 10-year range and year-by-year history

14.0Below average

BMY's p/e ratio is lower than 65% of the last 10 years.

P/E ratio History

Historically priceyAbove avgAround avgBelow avgHistorically cheap
BMY P/E ratio historyBMY P/E ratio from Sep 2023 to Sep 2026: low -17.09, high 22.88, latest 14.04.-20.29-8.72.8914.4926.08Sep 23Apr 24Nov 24Jun 25Feb 26Sep 26med 14.03

BMY P/E ratio by year

Yearly range of BMY’s p/e ratio from 2016 to 2026. Over the full period it ranged from -652.0 to 270.7, averaging -6.9.

BMY P/E ratio — yearly low, average, high and year-end values
YearLowAverageHighYear-end
202612.415.718.114.0
2025-14.310.522.915.6
2024-17.1-8.014.1-12.8
202312.318.225.313.0
202219.724.328.423.4
2021-30.5-23.120.020.0
2020-652.0-275.479.1-15.5
201911.315.029.329.3
201817.2131.0270.717.2
201717.721.425.724.1
201624.628.333.229.2

Get notified when BMY P/E ratio crosses a threshold

Free — one alert setup, notifications by push, Telegram, or Discord.

How much the market pays for each dollar of annual profit. P/E = Stock Price / EPS. The raw number means little — what matters is whether it's high or low relative to the company's own history.

FormulaPrice / Earnings Per Share
Full guide
How to read this chart

The chart shows five color-coded historical zones: green (below 10th percentile) means historically very cheap, fading through lime and gray (the normal 25th–75th range) to orange and red (historically expensive). When the line sits in a green or lime zone, the stock is trading at an unusually low P/E relative to its own history.

Key caveats
  • Cyclical businesses look cheapest on P/E at peak earnings — the "earnings trap." Use EV/EBITDA or normalised earnings for energy, materials, and financials.
  • A falling P/E trend may signal a business in structural decline, not a buying opportunity.

Is BMY P/E ratio High or Low Right Now?

Bristol-Myers Squibb Company's P/E ratio is currently 14.0, which is below average relative to its 10-year historical range. The 10-year median P/E ratio for BMY is approximately 17.5. See all BMY valuation metrics →

Pro — up to 30-year history

Unlock 10y, 15y, 20y, and 30y history with peer comparison and CSV export.